Verséa Health, Inc. is a transformative healthcare company on a mission to revolutionize healthcare by promoting Proactive Health, Preventive Care, and Precision Medicine.

By delivering innovative diagnostics, ophthalmic solutions, and groundbreaking discoveries, our vision is to shape the future where health and wellness are tailored to each person’s unique needs, ultimately empowering people to take control of their well-being.

Founded in Q4 2018 by Sean Fetcho, Steve Porada and Colby Fox the company is led by experienced C-suite executives with growth and acquisition experience across multiple market segments and distribution channels. The leadership is supported by an Advisory Board that comprises of leading academic and multidisciplinary clinical medical advisors.

Leveraging its channel expertise and strategic industry partnerships the company has been successful in building long-term trusted relationships with thousands of healthcare providers (physicians, practices, laboratories, and large medical centers) and retail companies throughout the country.

Verséa Health, Inc. holds exclusive global licenses, 5 patents and several pending, private labeled brands, proprietary digital and capital equipment assets.

Our Product Portfolio consists of:

• Point-of-care (POC), over-the-counter (OTC) and lab-based testing solutions for infectious and non-infectious diseases, drugs of abuse, pregnancy & ovulation,
• Comprehensive eye care product range that includes tear-based POC testing platform and complementary regenerative therapeutics,
• Personalized Mitochondrial Health Screening and two Research platforms used to accelerate the discovery and development of novel therapeutic drugs as well as provide a systemic view of cellular metabolism.

Verséa Health has 3 strategic business units:

Verséa Diagnostics

Verséa Ophthalmics

Verséa Discovery

Each business unit provides unique value to the healthcare community and drives commercial success of Verséa Health, Inc.